The linked FDA records tie Cook, Inc. to a single premarket approval number, P020018, covering Zenith endovascular graft systems for abdominal aortic and aorto-iliac aneurysm treatment. The original approval and a later manufacturing supplement show the same applicant name and product code MIH, with the Cardiovascular advisory committee listed on both. The record set is small and specific: two linked PMA records, one original approval and one 30-day notice. [1][2][5]
Original approval and stated indication
P020018 was approved on May 23, 2003, for the Zenith AAA Endovascular Graft and H&L-B One-Shot Introduction System, received by FDA on May 24, 2002. The approval statement describes the device as indicated for endovascular treatment of patients with abdominal aortic or aorto-iliac aneurysms having morphology suitable for endovascular repair. The record lists product code MIH, device class 3, and the Cardiovascular advisory committee, with a Federal Register notice date of July 11, 2003. [2]
Later supplement and manufacturing scope
Supplement S070 was received August 20, 2026, and decided September 17, 2026, under decision code OK30 as a 30-Day Notice. Its stated scope is approval for delivery system manufacturing changes for the Zenith Fenestrated AAA Endovascular Graft and Zenith Iliac Branch, filed as a process change affecting manufacturer, sterilizer, packager or supplier. The supplement carries the same PMA number, product code and Cardiovascular committee as the original approval. [1]
The Zenith Iliac Branch has its own FDA summary of safety and effectiveness under P020018/S064, with a notice of approval dated May 30, 2025, naming William A. Cook Australia Pty. Ltd. as applicant and listing the device generic name as endovascular graft with procode MIH. That summary states the original PMA covered the Zenith Flex AAA Endovascular Graft with Z-Trak Introduction System. The FDA PMA page for S064 notes that a supplement may have changed the device description, function or indication from the original approval. [5][8]
Published product documentation
Cook Medical's Zenith Iliac Branch instructions for use, document IFU-IBU-V004, set out a device description covering graft construction, delivery system, sizing options and compatibility, intended user and expected device lifetime. The same document carries symbols for a double sterile barrier system, single use only, MR Conditional status and prescription-only restriction, and identifies William A. Cook Australia Pty. Ltd. as the publisher. A later revision, IFU-IBU-V005, repeats the single-use, sterile-barrier and MR Conditional labeling. [3][9]
Cook Medical's product page for the Zenith Iliac Branch describes the device in anatomy and states that it is used with another Zenith component, while cautioning that not all products shown are approved in all regulatory jurisdictions. A separate Cook Medical page for the Zenith Fenestrated AAA Endovascular Graft references body lengths of 94 mm, 109 mm and 124 mm, and internal proximal stent body lengths of 107 mm, 122 mm and 137 mm, alongside an Essential Prescribing Information link. [4][6]
What the filings do and do not establish
The supplied collection contains two linked PMA records as of the snapshot date, one original approval and one 30-day notice, and no recall records. Those counts describe the supplied filings only and are not measures of total portfolio size, sales or safety performance. The records identify Cook, Inc. as applicant at a Bloomington, Indiana filing address; that address is a filing detail, not a verified headquarters. No parent, brand or ownership relationship is confirmed beyond the applicant names appearing in the cited documents. [1][2][5]


